MoonLake Immunotherapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MLTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
08 Oct 25	BuyUS$98,808	Matthias Bodenstedt	Individual	10,870	US$9.09
30 Sep 25	SellUS$18,548,556	Cormorant Asset Management, LP	Company	2,805,827	US$6.96
29 Sep 25	SellUS$28,319,628	Cormorant Asset Management, LP	Company	3,694,151	US$9.38

Insider Trading Volume

Insider Buying: MLTX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MLTX?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	4,610,071	6.46%
Individual Insiders	7,056,604	9.89%
Institutions	18,675,970	26.2%
Hedge Funds	19,751,284	27.7%
General Public	21,279,650	29.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 63.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
27.7%	BVF Partners L.P.	19,751,284	US$250.2m	0%	7.31%
6.46%	Deep Track Capital, LP	4,610,071	US$58.4m	0%	1.14%
4.45%	Kristian Reich	3,178,511	US$40.3m	3.13%	no data
4.31%	Jorge da Silva	3,078,577	US$39.0m	0%	no data
2.8%	Avoro Capital Advisors LLC	2,000,000	US$25.3m	-51.8%	0.29%
2.79%	Cormorant Asset Management, LP	1,994,173	US$25.3m	-76.5%	1.43%
2.38%	Balyasny Asset Management L.P.	1,699,235	US$21.5m	302%	0.05%
2.1%	Adage Capital Management, L.P.	1,500,000	US$19.0m	0%	0.03%
1.35%	Schonfeld Strategic Advisors LLC	965,405	US$12.2m	0%	0.09%
1.15%	T. Rowe Price Group, Inc.	822,957	US$10.4m	-68.5%	no data
1.02%	FMR LLC	724,868	US$9.2m	-87.3%	no data
0.89%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	634,474	US$8.0m	-15%	no data
0.88%	Matthias Bodenstedt	627,536	US$8.0m	1.76%	no data
0.83%	Medical Strategy GmbH	593,269	US$7.5m	0%	0.46%
0.64%	Two Sigma Investments, LP	454,268	US$5.8m	0%	0.01%
0.61%	Ikarian Capital, LLC	435,839	US$5.5m	0%	0.95%
0.51%	The Goldman Sachs Group, Inc.	362,871	US$4.6m	-71.1%	no data
0.45%	Marshall Wace LLP	321,109	US$4.1m	-39.3%	0.01%
0.38%	Verition Fund Management LLC	272,768	US$3.5m	1,060%	0.02%
0.37%	First Turn Management, LLC	262,643	US$3.3m	0%	0.42%
0.36%	Boothbay Fund Management, LLC	258,779	US$3.3m	0%	0.09%
0.35%	Morgan Stanley	252,673	US$3.2m	531%	no data
0.35%	Boxer Capital Management, LLC	250,000	US$3.2m	0%	0.87%
0.29%	Rhenman & Partners Asset Management AB	207,000	US$2.6m	360%	0.2%
0.27%	Schroder Investment Management Limited	195,490	US$2.5m	908%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/24 08:39
End of Day Share Price	2025/11/21 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MoonLake Immunotherapeutics is covered by 19 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Julian Harrison	BTIG
Prakhar Agrawal	Cantor Fitzgerald & Co.
Samantha Lynn Semenkow	Citigroup Inc